Skip to main content

Published locations for Palivizumab in preterm infants limits wheezing for 1 year

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Palivizumab in preterm infants limits wheezing for 1 year

User login

  • Reset your password
  • /content/palivizumab-preterm-infants-limits-wheezing-1-year
  • /familypracticenews/article/58710/pediatrics/palivizumab-preterm-infants-limits-wheezing-1-year
  • /ehospitalistnews/article/58710/pediatrics/palivizumab-preterm-infants-limits-wheezing-1-year
  • /pediatricnews/article/58710/pediatrics/palivizumab-preterm-infants-limits-wheezing-1-year
  • /pulmonary-health-hub/article/58710/pediatrics/palivizumab-preterm-infants-limits-wheezing-1-year
  • /pediatrics/article/58710/pediatrics/palivizumab-preterm-infants-limits-wheezing-1-year
  • /familymedicine/article/58710/pediatrics/palivizumab-preterm-infants-limits-wheezing-1-year
  • /chestphysician/article/58710/pediatrics/palivizumab-preterm-infants-limits-wheezing-1-year